The collaboration between ACVT and LBT Innovations won the SA Science Excellence award for Research Collaboration for the development of that APAS technology. APAS is an automated agar plate reader, which promises to greatly reduce the cost of this critical pathology procedure. APAS achieve first-in-class FDA approval last year.
We just had a piece on medical machine learning published in the Conversation.
The ACVT has been working with LBT Innovations, a South Australian medical device company, for more than 5 years on a new form of medical device to automate the reading of Agar plates. The processing of Agar plates is an important and time-consuming part of the normal operation of hospitals and clinics around the world. […]
From the LBT annual report: A ten-week pivotal clinical trial at TriCore Reference Laboratories in New Mexico during July and August 2015 tested APAS against a panel of microbiologists. Culture plates from 5,500 patients were processed by APAS and simultaneously assessed by a panel of independent qualified microbiologists. The results showed that APAS achieved over […]